The roles of mitochondrial tRNA mutations in non-dystrophic myotonias

According a recent report by Heidari et al., a mutational screening for candidate pathogenic mitochondrial tRNA (mt-tRNA) mutations were performed in 45 Iranian patients with non-dystrophic myotonia (NDM) and 70 control subjects. Through PCR amplification and direct sequence analysis, nine mt-tRNA m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xue-Jiao, Ding, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682739/
https://www.ncbi.nlm.nih.gov/pubmed/33367105
http://dx.doi.org/10.1080/23802359.2020.1839364
Descripción
Sumario:According a recent report by Heidari et al., a mutational screening for candidate pathogenic mitochondrial tRNA (mt-tRNA) mutations were performed in 45 Iranian patients with non-dystrophic myotonia (NDM) and 70 control subjects. Through PCR amplification and direct sequence analysis, nine mt-tRNA mutations were identified: tRNA(Met) T4454C, tRNA(Trp) A5568G, tRNA(Cys) T5794C, tRNA(Arg) A10438T and T10462C, tRNA(Leu(CUN)) A12308G, tRNA(Thr) A15907G, A15924G and G15928A. However, through the database searches and phylogenetic conservation analysis, we noticed that the tRNA(Thr) A15924G, G15928A and tRNA(Leu(CUN)) A12308G mutations should be classified ‘pathogenic’. Thus, the roles of mt-tRNA mutations in clinical expression of NDM needed to be further experimentally addressed.

Ejemplares similares